Join CvilleBioHub in San Francisco in mid-January at the 30th Annual J.P. Morgan Healthcare Conference and connect with high profile investors and meet other companies from the Commonwealth.

The CvilleBioHub has been awarded $548,000 from the GO Virginia initiative to lead the growth and expansion of the biotechnology innovation cluster in Central Virginia.

ZielBio, Inc., an early-stage biotechnology company that identifies novel high value disease targets and develops therapeutic interventions to improve patient outcomes, has closed a $25.1 million Series A financing round.

Jazz Pharmaceuticals, a global biopharmaceutical company dedicated to developing life-changing medicines for people with limited or no options, acquired Cavion, Inc., a Charlottesville, VA and Cambridge, MA-based clinical-stage biotechnology company.

Direct Spinal Therapeutics, Inc., a local biotech company, has earned the ninth investment from UVA Licensing and Ventures Group Seed Fund.

HemoShear Therapeutics, a company focused on discovering and developing drugs for metabolic disorders, recently appointed Kathleen M. Metters, PhD, to its board of directors.

Virginia Catalyst recently announced that it awarded $2.1 million in grants to four life and bioscience projects in the Commonwealth of Virginia.